Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mark I Gluzman

2PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jun 13, 2025
Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients.

Tatyana N Sokolova, Grigory A Yanus, Svetlana N Aleksakhina

|Apr 04, 2025
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma.

Ilya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko

Pageof 1

Frequent Collaborators

1 joint publications

Ilya Tsimafeyeu

1 joint publications

Alexander Sultanbaev

1 joint publications

Daria Dubovichenko

1 joint publications

Makhabbat Murzalina

1 joint publications

Alexander Volkov

1 joint publications

Rashida Orlova

1 joint publications

Igor Utyashev

1 joint publications

Grigory A Yanus

1 joint publications

Alisa S Nikitina

1 joint publications

Aleksandr S Martianov

Frequent Collaborators

1 joint publications

Ilya Tsimafeyeu

1 joint publications

Alexander Sultanbaev

1 joint publications

Daria Dubovichenko

1 joint publications

Makhabbat Murzalina

Top Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on : Aug 01, 2018

8.0K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos

Top Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on : Aug 01, 2018

8.0K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos